| Dr Travis Iksic, PHARMD | |
|
1340 N Wenatchee Ave, Wenatchee, WA 98801-1558 | |
| (509) 664-5111 | |
| (509) 663-9006 |
| Full Name | Dr Travis Iksic |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1340 N Wenatchee Ave, Wenatchee, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144760794 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PH60650021 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Travis Iksic, PHARMD 1340 N Wenatchee Ave, Wenatchee, WA 98801-1558 Ph: (509) 664-5111 | Dr Travis Iksic, PHARMD 1340 N Wenatchee Ave, Wenatchee, WA 98801-1558 Ph: (509) 664-5111 |
News Archive
Despite new implant technologies and surgical techniques leading to increased rates of spinal fusion surgery, the percentage of patients requiring further low-back surgery after spinal fusion has actually increased since the early 1990s, reports the Sept. 1 issue of the journal Spine, published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
A pricy drug used to treat a rare but well-known genetic disorder may hold wider promise as a treatment for millions of Americans with potentially lethal enlarged hearts, due mainly to high blood pressure, a study from Johns Hopkins shows.
Pain impacts nearly every individual at some point in their lives. With more than 25 million adults in the U.S. experiencing daily pain, the U.S. is facing a crisis due to the high prevalence of chronic pain and associated opioid use disorder and overdose deaths.
Covidien, a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of Somanetics Corporation for an aggregate consideration of approximately $250 million, net of cash and short-term investments acquired.
STERIS Corporation today announced financial results for its fiscal 2011 first quarter ended June 30, 2010. During the first quarter, the Company recorded the previously announced liability related to the SYSTEM 1 Rebate Program. Of the $110 million pre-tax amount recorded, $102 million is attributable to the Customer Rebate portion of the Program and was recorded as a reduction of revenues, and $8 million is attributable to the disposal of the SYSTEM 1 units to be returned and was recorded as an increase in cost of revenues.
› Verified 4 days ago
Alaa Salama, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Dr. Grant Thomas Florer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 590-665-5835 | |
Mr. Douglas Fischer, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1201 S Miller St, Wenatchee, WA 98801 Phone: 509-662-1511 | |
Eli Yarwood, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2000 N Wenatchee Ave, Wenatchee, WA 98801 Phone: 509-664-3698 Fax: 509-665-8505 | |
Kellie M Dillin, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 600 Orondo Ave, Ste 1, Wenatchee, WA 98801 Phone: 509-664-3508 Fax: 509-664-4591 | |
Valerie Barnett, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-665-5888 | |
Danica Mito, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1201 S Miller St, Central Washington Hospital Inpatient Pharmacy, Wenatchee, WA 98801 Phone: 509-661-3513 Fax: 509-665-6213 |